A review on potential biotechnological applications of microalgae

Journal of Applied Pharmaceutical Science

Volumn 6, Issue 8, 2016, Pages 179-184

  Sigamani, Santhosh ^a   Ramamurthy, Dhandapani ^a   Natarajan, Hemalatha ^a  

^a PERIYAR UNIVERSITY   (India)

Author keywords

Compound; Extraction; Metabolites; Microalgae; Toxins

Indexed keywords

EID: 84985916784     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: 10.7324/JAPS.2016.60829     Document Type: Article

References (75)

1. Abdulqader G, Barsanti L, Tredici MR. Harvest of Arthrospira platensis from Lake Kossorom (Chad) and its household usage among the Kanembu. J Appl Phycol 2000; 12: 493-498.
2. Amaro HM, Barros R, Guedes AC, Sousa-Pinto I, Malcata FX. Microalgal compoundsmodulate carcinogenesis in the gastrointestinal tract. Trends in Biotechnology, 2013; 31(2): 92-98.
3. Asha P, Nira KS, Ashok P, Edgard G, Datta M. Cyanobacteria and microalgae: a positive prospect for biofuels. Bioresour. Technololgy, 2011; 102: 10163-10172.
4. Ayehunie S, Belay A, Baba TW, Ruprecht RM. Inhibition of HIV-1 replication by an aqueous extract of Spirulina platensis. J Aquir Immun Defic Syndr Hum Retrovirol, 1998; 18: 7-12.
5. Barsanti L, Gualtieri P. Algae: anatomy, biochemistry and biotechnology. Florida: Taylors R Francis Group, 2006; 301.
6. Belay A. Spirulina (Arthrospira): production and quality assurance. In: Gershwin ME, Belay A, eds. Spirulina in human nutrition and health. Boca Raton: CRC Press, 2008; 1-25.
7. Blunt W, BL. Copp, M. H. G. Munro, P. T. Northcote, and M. R. Prinsep, "Marine natural products.Natural Product Reports, 2006; 23:1426-78.
8. Boopathy NS, Kathiresan K. Anticancer drugs from marine flora; an overview. J Oncol, 2010; Article ID 214186: 18
9. Brennan L and Owened PAuthor Vitae Biofuels from microalgae A review of technologies for production, processing and extractions of biofuels and co-products. Renewable and Sustainable Energy Reviews, 2010; 14(2):557-577.
10. Burja AM, Banaigs B, Abou-Mansour E, Burgess JG and Wright PC Marine cyanobacteria-a prolific source of natural products. Tetrahedron, 2001; 57:9347-9377.
11. Carmichael WW. Health effects of toxin-producing cyanobacteria: the CyanoHabs. Hum Ecol Risk Assess, 2001;7:1393-1407.
12. Chisti, Y. Biodiesel from microaglae. Biotechnology. Advances, 2007; 25: 294-396.
13. Chu WL, Lim YW, Radhakrishnan AK, Lim PE. Protective effect of aqueous extract from Spirulina platensis against cell death induced by free radicals. BMC Complement Altern Med 2010; 10: 53
14. Chu WL, See TC, Phang SM. Use of immobilised Chlorella vulgaris for the removal of colour from textile dyes. J Appl Phycol, 2009; 21: 641-648.
15. Chu WL. Potential applications of antioxidant compounds from algae. Curr Top Nutraceut Res 2011; 9: 83-98. 13.
16. Converti A, Casazza AA, Ortiz EY, Perego P, Borghi MD. Effect of temperature and nitrogen concentration on the growth and lipid content of Nannochloropsis oculata and Chlorella vulgaris for biodiesel production, Chemical Engineering and Processing: Process Intensification, 2009; 48: 1146-1151
17. De Jesus Raposo MF, De Morais RMSC, and Morais AMMB. Health applications of bioactive compounds from marine microalgae.Life Sciences, 2013; 93(15):479-486.
18. De-Bashan, LE, Moreno M, Hernández JP, Bashan Y. Removal of ammonium and phosphorus ions from synthetic wastewater by the microalgae Chlorella vulgaris coimmobilized in alginate beads with the microalgae growth-promoting bacterium Azospirillum brasiliense. Water Res 2002; 36: 2941-2948.
19. Demirbas A. Use of algae as biofuel sources. Energ Convers Manage, 2010; 51:2738-2749.
20. Dey B, Lerner DL, Lusso P, Boyd MR, Elder JH, Bergeri EA. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus Type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses. J Virol, 2000; 74: 4562-4569
21. Durmaz Y. Vitamin E (tocopherol) production by the marine microalgae Nannochloropsis oculata (Eustigmatophyceae) in nitrogen limitation, Aquaculture, 2007; 272:717-722.
22. Furusawa E, Moore RE, Mynderse JS, Norton TR, Patterson GML. New purified culture of Scytonema pseudohofmanni ATCC 53141 is used to produce scytophycins A, B, C, D and E, which are potent cytotoxins and antineoplastic agents, USA Patent Number 5281533, 1994;
23. Garcia-Camacho F, Gallardo-Rodriquez J, Sanchez-Miron A, CeronGracia MC, Belarbi EH, Chisti Y, Molina-Grima E. Biotechnological significance of toxic marine dinoflagellates. Biotechnol Adv, 2007; 25: 176-194
24. Gerwick WH, Roberts MA, Proteau PJ, Chen JL. Screening cultured marine microalgae for anticancer type activity. J Appl Phycol, 1994; 6: 143-149.
25. Gouveia L, Batista AP, Sousa I, Raymundo A, Bandarra NM. Microalgae in novel food products. In Food Chemistry Research Developments. Edited by: Papadopoulos KN. Hauppauge, NY: Nova Science Publishers, Inc., 2008;1-37.
26. Hallegraef GM. Harmful algal blooms: a global overview. In: Hallegraef GM, Andersen DM, Cembella AD, eds. Manual on harmful marine microalgae. Paris: UNESCO Publishing, 2003; 25-49.
27. Han D, Bi Y, Hu Z. Industrial production of microalgal cell-mass and secondary products-species of high potential. Nostoc. In: Richmond A, ed. Handbook of microalgal culture: biotechnology and applied phycology. Oxford: Blackwell Science, 2004; 304-311.
28. Hayashi K, Hayashi T, Kojima I. A natural sulfated polysaccharide, calcium spirulan, isolated from Spirulina platensis in vitro and ex vivo evaluation of anti-herpes simplex virus and anti-human immunodeficiency virus activities. AIDS Res Hum Retrovir, 1996; 12: 1463-1471.
29. He J, Yang Y, Xu HY, Zhang X, Li XM. Olanzapine attenuates the okadaic acid-induced spatial memory impairment and hippocampus cell death in rats. Neuropsychopharmacology, 2005; 30: 1511-1520.
30. Higuera-Ciapara I, Felix-Valenzuela L, Goycoolea FM. Astaxanthin: a review of its chemistry and applications. Crit Rev Food Sci Nutr, 2006, 46: 185-196.
31. Huleihel M, Ishamu V, Tal J, Arad SM. Antiviral effect of red microalgal polysaccharides on Herpes simplex and Varicella zoster viruses. J Appl Phycol, 2001; 13: 127-134.
32. Ibañez E and Cifuentes A. Benefits of using algae as natural sources of functional ingredients.Journal of the Science of Food and Agriculture, 2013; 93(4):703-709.
33. Irwandi J, Farida O. Mineral and heavy metal contents of marine fin fish in Langkawi Island, Malaysia. Int Food Res J, 2009; 16: 105-112.
34. Ishibashi M, Moore RE, Patterson GML, Xu C, Clardy J. Scytophycins, cytotoxic and antimycotic agents from the cyanophyte Scytonema pseudohofmanni. J Org Chem, 1986; 51: 5300-5306.
35. Ismail M. Phytoplankton and heavy metal contamination in the marine environment. In: Phang SM, Brown M, eds. Biomonitoring in tropical coastal ecosystems, Kuala Lumpur: University of Malaya Maritime Research Centre (UMMrec), 2004; 15-96.
36. Iwamoto H. Industrial production of microalgal cell-mass and secondary products-major industrial species. Chlorella. In: Richmond A, ed. Handbook of microalgal culture: biotechnology and applied phycology. UK: Blackwell Science, 2004; 255-263.
37. Iwata K, Inayama T and Katoh T. Effect of Spirulina platensis on plasma lipoprotein lipase activity in fructose induced hyperlipidemia in rats. J. Nutr. Sci. Vitaminol, 1990; 36:165-171
38. Iyer UM, Dhruv SA, Mani IU. Spirulina and its therapeutic implications as a food product. In: Gershwin ME, Belay A, eds. Spirulina in human nutrition and health. Boca Raton: CRC Press, 2008; 51-70.
39. Jung JH, Sim CS, Lee CO. Cytotoxic compounds from the twosponge association. J Nat Prod, 1995; 58: 1722-1726.
40. Kobayashi J, Shimbo K, Kubota T, Tsuda M. Bioactive macrolides and polyketides from marine dinoflagellates. Pure Appl Chem, 2003; 75: 337-342.
41. Lipton AP. Marine bioactive compounds and their application in mariculture. Marine Ecosystem, Univ. of Kerala, Kariavattom, 2003; 2(4): 695-701.
42. Lorenz RT, Cysewski GR. Commercial potential for Haematococcus microalgae as a natural source of astaxanthin. Trends Biotechnol, 2000; 18: 160-167.
43. Mani UV, Iyer UM, Dhruv SA, Mani IU, Sharma KS. Therapeutic utility of Spirulina. In: Gershwin ME, Belay A, eds. Spirulina in human nutrition and health. Boca Raton: CRC Press, 2008; 71-99.
44. Markou G and Nerantzis E. Microalgae for high-value compounds and biofuels production: a review with focus on cultivation under stress conditions. Biotechnology Advances, 2013, 31:8, 1532-1542.
45. Mata TM, Martins AA, Caetano NS. Microalgae for biodiesel production and other applications: a review. Renew. Sust. Energy Res., 2010; 14: 217-232.
46. Mayer MS and Hamann MT, "Marine pharmacology in 2001-2002: marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action, " Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 2004;140:3:265-286,
47. 2 extraction of γ-linolenic acid and other lipids from Arthrospira (Spirulina)maxima: comparison with organic solvent extraction, " Food Chemistry, 2006; 99(1):57-63,
48. Metting FB. Biodiversity and application of microalgae. J Ind Microbiol, 1996; 17: 477-489.
49. Michele Greque deMorais, Bruna da SilvaVaz, Etiele Greque de Morais, and Jorge Alberto Vieira Costa. Biologically Active Metabolites Synthesized by Microalgae. BioMed Research International, 2015; 7-15.
50. Mulbry W, Kondrad S, Buyer J.Treatment of dairy and swine manure effluents using freshwater algae: fatty acid content and composition of algal biomass at different manure loading rates. J. Appl. Phycol., 2008; 20: 1079-1085.
51. Mulbry W, Westhead EK, Pizarro C, Sikora L. Recycling of manure nutrients: use of algal biomass from dairy manure treatment as a slow release fertilizer. Bioresource Technology, 2005; 96: 451-458.
52. Nobre F, Marcelo R. Passos. Supercritical carbon dioxide extraction of astaxanthin and other carotenoids from the microalga Haematococcus pluvialis. European Food Research and Technology, 2006; 223(6): 787-790.
53. Oltra C. Stakeholder perceptions of biofuels from microalgae. Energy Policy, 2011; 39:1774-1781.
54. Palavra AMF, Coelho JP, Barroso JG. Supercritical carbon dioxide extraction of bioactive compounds from microalgae and volatile oils from aromatic plants, Journal of Supercritical Fluids, 2011; 60: 21-27.
55. Patil KJ, Patil VA, Mahajan SR, Mahajan RT. Bio-activity of algae belonging to Bhusawal region, Maharashtra. Curr Bot, 2011, 2:29-31.
56. Patterson GML, Baker KK, Baldwin CL, Bolis CM, Caplan FR, Larsen LK, et al. Antiviral activity of cultured blue-green algae (Cyanophyta). J Phycol, 1993;29: 125-130.
57. Patterson GML, Baldwin CL, Bolis CM, Caplan FR, Karuso H, Furusawa E et al. Antineoplastic activity of cultured blue-green algae (Cyanobacteria). J Phycol, 1991; 27: 530-536.
58. Pienkos P, Darzins A. The promise and challenges of microalgal derived biofuels. Biofuel Bioprod Bior, 2009; 3:431-440.
59. Plaza M, Herrero M, Cifuentes A, Ibáñez E. Innovative natural functional ingredients from microalgae. J Agric Food Chem, 2009; 57:7159-7170.
60. Plaza M, Santoyo S, Jaime L. Screening for bioactive compounds from algae. Journal of Pharmaceutical and Biomedical Analysis, 2010; 51, 2, 450-455.
61. Priyadarshani I and Rath B, Commercial and industrial applications of micro algae-a review, Journal of Algal Biomass Utilization, 2012; 3:4, 89-100
62. Pulz O, Gross W. Valuable products from biotechnology of microalgae. Appl Microbiol Biotechnol, 2004: 65:635-648.
63. R. Carvalho, A. Costa-Neves, G. A. A. Conserva "Biologically active compounds from cyano bacteria extracts: in vivo and in vitro aspects, " Brazilian Journal of Pharmacognosy, 2013; 23(3):471-480, 2013.
64. Richmond A. Handbook of microalgal culture: biotechnology and applied phycology. Blackwell Science Ltd, 2004.
65. Rodríguez-Meizoso L. Jaime S. Santoyo "Pressurized fluid extraction of bioactive compounds from Phormidium species, " Journal of Agricultural and Food Chemistry 2008; 56, 10, 3517-3523.
66. Ruiz-Marin A, Mendoza-Espinosa L, Stephenson T. Growth and nutrient removal in free and immobilized green algae in batch and semi-continuous cultures treating real wastewater. Bioresource Technology, 2010; 101: 58-64.
67. Schwartz RE, Hirsch CF, Sesin DF, Flor JE, Chartrain M, Fromtling RE. Pharmaceuticals from cultured algae. J Ind Microbiol, 1990; 5: 13-123
68. Singh NK and Dhar DW. Microalgae as second generation biofuel. A review.Agronomy for Sustainable Development, 2011; 31(4):605-629.
69. Spolaore P, Joannis-Cassan C, Duran E, Isambert A. Commercial applications of microalgae. J Biosci Bioengrg, 2006; 101: 87-96.
70. Stevenson CS, Capper EA, Roshak AK, Marquez B, Echman C, Jackson JR, Mattern M. The identification and characterization of the marine natural product scytonemin as a novel antiproliferative pharmacophore. J Pharmacol Exp Ther, 2002; 303: 858-866.
71. Sukenik A, Cohen Z, in: Cohen Z (Ed.), Chemicals from Microalgae, Taylor & Francis; 1999 (Chapter 3).
72. Tsai CC, Emau P, Jiang Y, Agy MB, Shattock RJ, Schmidt A et al. Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models. AIDS Res Human Retrovir, 2004; 20: 11-18.
73. Walker TL, Purton S, Becker DK. Collet C: Microalgae as bioreactors. Plant Cell Rep, 2005; 24:629-641.
74. Wijffels RH, Barbosa MJ. An outlook on microalgal biofuels. Science, 2010; 329:796-799.
75. Yuan JP, Peng J, Yin K, Wang JH. Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae. Mol Nutr Food Res, 2011; 55: 150-165.